Ipilimumab/pembrolizumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1909卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16593-2

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：306 / 306

相关论文

共 50 条

[1] Ipilimumab/pembrolizumabHypophysitis: case report
Reactions Weekly, 2024, 2028 (1) : 256 - 256
[2] Ipilimumab/pembrolizumabHypophysitis: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 268 - 268
[3] Ipilimumab/pembrolizumabHypophysitis: 10 case reports
Reactions Weekly, 2015, 1576 (1) : 162 - 162
[4] Ipilimumab/pembrolizumabHypophysitis: 2 case reports
Reactions Weekly, 2018, 1714 (1) : 242 - 242
[5] Ipilimumab/Nivolumab/PembrolizumabHypophysitis: 3 case reports
Reactions Weekly, 2024, 2037 (1) : 222 - 222
[6] PembrolizumabHypophysitis: case report
Reactions Weekly, 2021, 1837 (1) : 570 - 570
[7] PembrolizumabHypophysitis: case report
Reactions Weekly, 2025, 2042 (1) : 408 - 408
[8] PembrolizumabHypophysitis: case report
Reactions Weekly, 2022, 1937 (1) : 390 - 390
[9] PembrolizumabHypophysitis: case report
Reactions Weekly, 2019, 1755 (1) : 261 - 261
[10] PembrolizumabHypophysitis: case report
Reactions Weekly, 2022, 1900 (1) : 272 - 272

← 1 2 3 4 5 →